Submitted by pattersonj on Fri, 04/17/2015 - 16:47
Scientists in the United States have made many discoveries in biomedical research and increased our understanding of the causes, treatment, and prevention of many diseases. Yet scientific advances in research are often slow or fail to fulfill their promise and potential for improving community health. It is the ICTS’s mission to speed this process of translating basic research findings into clinical and community practice to reach individual patients and communities.
Submitted by pattersonj on Fri, 03/06/2015 - 15:19
Immunology research at the University of Iowa is showcased in the journal Immunologic Research, which devotes its August issue (http://link.springer.com/journal/12026/59/1/page-1) entirely to articles by UI researchers covering a wide range of studies on the immune system and its role in health and disease.
This is the third time in 14 years that the UI has been selected by editors of this journal as a featured center.
Submitted by pattersonj on Fri, 03/06/2015 - 14:58
"When Edith Parker (Associate Director of the ICTS Community-based Research Core) connected my team with leaders from Iowa State University Extension and Outreach, it really stimulated us to think creatively about how we could collaborate to reach people in rural Iowa. I’m thankful to have had the chance to consult with Edith and benefit from her expertise and connections. Our collaborators at ISU Extension and Outreach are terrific people who share similar goals to improve the health and well-being of Iowans.
Submitted by pattersonj on Fri, 03/06/2015 - 14:36
A new initiative through the UI Health Alliance, a relationship between UI Health Care and Mercy Medical Center in Cedar Rapids was recently announced that offers enhanced care to Cedar Rapids-area patients.
Submitted by pattersonj on Fri, 03/06/2015 - 13:10
Biomedical research at universities produces a steady stream of promising new pharmaceuticals and medical procedures, and clinical trials are a critical step in assessing their efficacy and safety before taking them to market.
But the process and negotiations involved in getting those trials off the ground—especially for studies taking place at multiple sites simultaneously—can be daunting.